Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

4 Healthcare Stocks That Will Take Care of You

By Faisal Humayun, InvestorPlace Contributor
These healthcare stocks can deliver steady growth in the coming decade as demographics suggest tailwinds for the industry.

Novavax Is Worth $165 Once Its Covid-19 Vaccine Is Ready

By Mark R. Hake, CFA
NVAX stock is set to move higher once its Covid-19 vaccine is ready. If its clinical trials succeed, NVAX stock is worth $165 per share, or 61% higher than today.

Airlines Are Struggling, but Delta Stock Is the Best of the Legacy Carriers

By Ian Bezek, InvestorPlace Contributor
The vaccines haven't cured the airline industry's problems yet. However, DAL stock will be able to withstand the bumps along the way.

3 Wild Stocks to Buy Now to End 2020 With a Bang

By Nicolas Chahine, InvestorPlace Contributor
These three momentum stocks make for great stocks to buy into 2021. They have excellent fundamentals and they trade well short term.

Nio Stock Is an Electric Vehicle Rally Winner

By Lou Carlozo, InvestorPlace Contributor
if you bought $1,000 worth of Nio shares in January, you’d be sitting on $14,500 today. Who needs gas in the tank when you’ve got that kind of voltage?

Lordstown Motors Stock Looking Good for a Smooth EV Road Trip

By Lou Carlozo, InvestorPlace Contributor
Some stocks look like portfolio winners. Others strive to make a difference for an environment at the crossroads. And still others come with the promise of economic transformation for a downcast local economy. When you purchase RIDE stock, you get the rare chance to own all three.  

Xpeng Will Continue to Deliver for Shareholders in 2021

By Will Ashworth, InvestorPlace Contributor
Chinese electric vehicle maker Xpeng reported excellent earnings Nov. 12. Although XPEV stock is expensive, it’s still worth owning.

Arm Deal, AI Strength Should Propel Nvidia Stock Higher

By Larry Ramer, InvestorPlace Contributor
The Arm Holdings deal is poised to give Nvidia one of the best cross-selling opportunities in history, driving NVDA stock even higher.

Why Canopy Growth Is The Best Cannabis Stock

By Wayne Duggan, InvestorPlace Contributor
CGC stock has been a top performer among cannabis stocks in 2020. However, it's nowhere near its peak valuation, and it has more room to run.

7 ESG Investing Ideas That Could Add to Your Wallet and to Your Soul

By Tezcan Gecgil, InvestorPlace Contributor
ESG investing can help create value both for society and shareholders. These seven ESG stocks are a good place to start.

DraftKings Is Set to Climb From October-end Dip After Solid Q3 Report

By Larry Sullivan, InvestorPlace contributor
Investors who like to buy the dip should look hard at DKNG stock as the sports gaming company is poised to recover from its October-end low.

7 Cheap Stocks Ready for Big Gains in 2021

By Joel Baglole, InvestorPlace Contributor
Not all stocks have exhausted their 2020 rally. These seven cheap stocks are likely to provide investors with healthy gains.

4 Top Stock Trades for Friday: NKLA, DE, NIO, CRSR

By Bret Kenwell, InvestorPlace Contributor
Nikola, Deere, Nio and Corsair Gaming were our top stock trades for Friday. Let's feast our eyes on the charts before we feast on turkey.

4 AI Stocks on the Cutting Edge

By Faizan Farooque, InvestorPlace Contributor
AI stocks present the next frontier of investment, and these four companies are revolutionizing how we interact with their services.

Investors Should Ignore Valuation Concerns and Invest in Fastly

By Muslim Farooque, InvestorPlace Contributor
Fastly stock will continue at its lofty pace despite recent customer-specific challenges that came to light in the third quarter.

Here’s Why Boeing Stock Looks Like a Good Turnaround Play

By Mark R. Hake, CFA
Boeing stock looks like a good turnaround play because its average annual gain could be 35% over the next two years for some investors.

Overlook Novavax at the Risk of Incurring an Opportunity Cost

By Josh Enomoto, InvestorPlace Contributor
Although Pfizer and Moderna have stolen the headlines, there are still ample opportunities for upside with NVAX stock.

7 Canadian Stocks to Buy for Improved International Relations

By Alex Sirois, InvestorPlace Contributor
Canadian stocks will fare better under improved international relations in 2021. These seven stocks have the right fundamentals to rise.

3 Stocks to Buy for a Plant-Based Food Surge

By Divya Premkumar, InvestorPlace Contributor
Plant-based stocks are heating up as customers look for alternative meat products over environmental and animal welfare concerns.
Load More Articles